Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Semaglutide 2.4 mg

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 4 TRIAL

Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

ClinicalTrials.gov

This is a registered but ongoing Phase 4 randomized trial with no results reported; it is a study plan, not evidence of efficacy or safety.

PreliminaryNCT07275697 Emma Svennberg Atrial Fibrillation (AF)

Reported

Planned sample size200

Primary outcome measureArrhythmia-free survival at 12 months after…

Allocation ratio1:1

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support